chrisvoncsefalvay/vaers-outcomes huggingface dataset:
pt recv vax 16OT95 & 5JUN96 pt devel a typical chickenpox rash w/40 to 50 vesicular, erythematous lesions;vesicles were scattered on the trunk, neck, face & upper extremities;pt had a temp of 100.8 & h/a;pt recovered;
Patient complained of breathing being different.  She was nervous before and after vaccine.  Vitals were taken:  BPO 137/83, O2 99%, heart rate 94, respiration 20.  Advised patient to take deep breaths and remain calm.  Used anxiety techniques, monitored for additional 15 minutes.  Patient stated she felt better, and was cleared.
Patient presented 7 days after vaccination with left sided Bell's palsy. Referred to neurology after being placed on oral steroids. Left face flaccid, DX Bell's Palsey. Neuro referral provided. 11/17/06-continues with normal sensation. Slight decrease ton of Left?Right with 4/5 strength. DX: bell's Palsy, fever, pharnygitis-strep, URI.
Gave shot 3-27-07 that night arm very sore could not lift. 3-28-97 started with fever of 101.9 and rash just below injection site. Very tired, nauseous, no rash present when seen in office at 1845 on 3/28/07.
Information has been received from a medical assistant concerning a female patient who was vaccinated with the first doses of Gardasil. Subsequently, the patient experienced incredible mood swings. Subsequently, the patient recovered. On an unspecified date, the patient was vaccinated with a second dose of Gardasil. Subsequently, the patient experienced incredible mood swings. Subsequently, the patient recovered. On 07-JUL-2007, the patient was vaccinated with the third dose of Gardasil. At the time of the report, the physician was waiting to hear from the patient as to whether she had the same symptoms. Additional information has been requested.
The patient's first menstrual cycle occurred weeks after the vaccine, and has been very irregular ever since. The patient is now 24 years old and still has irregular menstrual cycles. It is currently unknown whether sterility has occurred. However, reproductive viability seems questionable as the menstrual cycles do not exceed 21 days on average. The typical range is 17-22 days per cycle.
Patient received the MMR vaccine at the pediatrician's recommendation on March 4th, 2015. On the ninth day following the shot, March 13th, she developed a fever and seemed 'not well', then started having diarrhea the next morning, March 14th. She had a fever most of March 13th-15th, and it lingered on and off through the 17th. The diarrhea was extremely foul and runny and around 10+ times a day from March 14th-March 16th. It has remained runny and FOUL, (I know that diarrhea doesn't smell good, but this is the worst I've ever smelled, and I have 3 children and have taken care of them when sick for 13 years now, this smells different) still, but since the 17th, it's only 1-4 times per day. We've tried the BRAT diet, and it didn't help, plus she's become picky about food, so I'm basically feeding her whatever she will eat. When I called the nurse advice line, I was told 'She probably just picked up a virus, just let it run it's course.' ... There are 5 people in my house, and no one else has been sick. At all.  I have not taken her to a hospital yet for this, because it doesn't seem to be life-threatening, however, if her docotor or someone doesn't help me get her straightened out soon, or it doesn't just clear up on it's own, I will be taking her for testing. Going on 3 weeks of diarrhea for such a little child, I know she can't possibly be absorbing any nutrients at this point.
Koplik's spots in the mouth; rash with red blanching dots on the trunk, extremities, stomach, back, and face; runny nose; rash with red blanching dots on the trunk, extremities, stomach, back, and face; This spontaneous report was received from a nurse and refers to a 12-month-old female patient. There was none pertinent medical history and drug reactions or allergies. No information about the patient's concomitant medications was provided.  On 10-JAN-2020 the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA (recombinant human albumin)) (PROQUAD) lot number: S013711, expiration date: 01-NOV-2020 (exact dose was not provided) subcutaneously as 1 year wellness visit vaccines. Other suspect therapies included sterile diluent (STERILE DILUENT) (dose, route of administration, indication, lot # and expiration date were not reported).  On 20-JAN-2020, the patient had runnny nose and rash with red blanching dots on the trunk, extremities, stomach, back, and face, and Koplik's spots in the mouth (considered as mild case of measles). The patient sought medical attention. No treatment was given for the events and no lab diagnostics or studies were performed. Lot check was requested. The reporter was interested in Varicella Zoster Virus (VZV) analysis by Polymerase Chain Reaction (PCR) and wanted to send viral isolates.  The outcome of the events was reported as resolved on an unknown date.  The relatedness between the events and the suspect vaccine was not provided.  Upon internal review, the event of Koplik's spots in the mouth was considered to be medically significant.  Additional information has been requested.  This is one of five cases received from the same reporter.; Sender's Comments:  US-009507513-2002USA001548: US-009507513-2002USA001507: US-009507513-2002USA001496: US-009507513-2002USA001134:
Localized swelling and redness to left deltoid that extended down to left elbow, patients father denies any SOB, wheezing, or difficulty breathing. Symptoms started Saturday 01/13/2018 per patients father, patient seen today in clinic for a sick visit, father showed provider patients arm and the redness an swelling are better with very minimal reaction left.  Patients father advised to alternate ice/heat to site to help with redness and swelling and to call 911 or go to ER is any SOB or wheezing should occur.
Day 2 102 fever and severe nausea Day-3-5 fever gone, nausea continued Day 5 - severe stiff neck Stiff neck , groin pain and shoulder stiffness continued through September.  Blood work revealed I had Polymyalgia Rheumatica and placed on prednisone  Not much relief.  Started seeing (Rheumatologist) more blood work groin pain and knee pain improved but shoulders did not.  Cray and MRi revealed tendinitis, fluid and rotator cuff tears in both shoulders. Frozen shoulder.  Stopped prednisone.  Started physical therapy and acupuncture  I am now going into my 7th week of therapy without much relief. Slight groin pain  now and then and knees are very sore.
Information has been received from a physician, via a company representative, concerning an 18 year old female patient, who on 28-JUN-2007 was vaccination with the third dose of Gardasil (lot # not provided). On 28-JUN-2007, the patient passed out three times. Blood pressure was 90/60mmHg following both the first and second episode. As the staff was taking the second blood pressure reading, she again passed out: her blood pressure following the third episode was 100/60mmHg. The physician considered the patient to be recovered on the same day, 28-JUN-2007. Additional information has been requested.
Tested positive again on home covid test; This spontaneous case was reported by a nurse and describes the occurrence of COVID-19 (Tested positive again on home covid test) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. J22A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension, Hypercholesterolemia, Obesity and Penicillin allergy.    On 31-Mar-2022 at 4:30 PM, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Tested positive again on home covid test). The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) from 22-May-2022 to 26-May-2022 for COVID-19 treatment, at an unspecified dose and frequency. At the time of the report, COVID-19 (Tested positive again on home covid test) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-May-2022, SARS-CoV-2 test: negative (Negative) Tested negative 2 days after finishing Paxlovid.. On 01-Jun-2022, SARS-CoV-2 test: positive (Positive) Tested positive again on home covid test..     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided.  Patient was not taking any other medications/products within 2 weeks of starting COVID-19 treatment.  On 31-May-2022 COVID symptoms returned.   Device Date was reported as 01-Jun-2022.  Patient did not took treatment medication after testing positive on 01-Jun-2022.  CC: This spontaneous case concerns a 65 year-old female patient, with no relevant medical history reported, who experienced the unexpected, non-serious Adverse Event of Special Interest of COVID-19,  which occurred unknown days after the fourth dose of mRNA-1273 vaccine administration. The ongoing COVID-19 pandemic could be a confounder for the event. The outcome of the event was reported as not resolved. The date of the initial COVID-19 diagnosis was not provided. Patient received Paxlovid as treatment of COVID-19 for duration of 5 days and reported testing negative 2 days after finishing Paxlovid. However 3 days later COVID-19 symptoms returned and tested positive again 1 day later. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.; Sender's Comments: This spontaneous case concerns a 65 year-old female patient, with no relevant medical history reported, who experienced the unexpected, non-serious Adverse Event of Special Interest of COVID-19,  which occurred unknown days after the fourth dose of mRNA-1273 vaccine administration. The ongoing COVID-19 pandemic could be a confounder for the event. The outcome of the event was reported as not resolved. The date of the initial COVID-19 diagnosis was not provided. Patient received Paxlovid as treatment of COVID-19 for duration of 5 days and reported testing negative 2 days after finishing Paxlovid. However 3 days later COVID-19 symptoms returned and tested positive again 1 day later. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.
PT IS A MINOR, SHE ENTERED THE MVU WITH THE AUTORIZATION OF HER MOM TO RECEIVE HER SECOND DOSE OF PFIZER. AFTER ASSESSING HER PT ANSWERED ALL THE QUESTIONS ASKED, SHE ALERT AND ORIENTED X3 SHE WAS EDUCATED ON WHAT TO DO AFTER RECEIVING THE VACCINE. WHILE SHE SAT DOWN FOR OBSERVATION FOR 15 MINUTES SHE REPORTED SHE FELT DIZZY AROUND 1635. WE ASSESSED HER INSIDE THE BUS. PT IS CONSCIOUS MOM SAID SHE WANTED TO DRIVE HER TO HOSPITAL. STAFF WALKED WITH HER TO MOMS CAR
The patient developed urticaria 12 days after obtaining his third dose (booster dose) of the Moderna vaccine.  Dose 1 and 2 were given March 23, 2021 and April 20, 2021, and he had no problems with the first two doses.
Fever up to 104, body aches, chills, headaches Tylenol and Motrin alternated every 5 hours Symptoms started on Wednesday 1/27/21 @ 2am and finished on Thursday morning 1/29/2021
Headache; Chills; Fever; This is a spontaneous report from a contactable consumer (reporting for them self).  A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on 09Jan2021 at a single dose for COVID-19 immunization. The patient's medical history was and concomitant medications were not reported.  The patient experienced headache, chills and fever in Jan2021.  The clinical outcome of headache, chills and fever was not recovered.    The batch/lot number for the vaccine, BNT162B2, was not provided and will be requested during follow-up.
After the Pfizer injection, I waited for 30 minutes at the hospital.   I drove home and began having a terrible headache/migraine (which I do NOT get/have).  My left arm was sore which I expected based on family members input.   I then broke out with a slight rash on my left arm and then welts began to appear on my left shoulder.   I showered with an oatmeal bar to help relieve the itching and reduce the swelling.   I continued to drink fluids on Wednesday from 5 to 1030 p.m.   The nurse at the hospital that gave me the injection suggested Tylenol and fluids.  I did both.  On Thursday from 7 a.m.  to approx  1 p.m. the headache and pounding remained.  I was lethargic and just slept.  Very little energy and had sensitivity to light on Thursday.   Loss of appetite.  This occurred from Thursday through late Saturday afternoon.  I also began to have shingles appear/small bumps that have now begun to fade on my left trunk, calf and right calf.  They began to appear early Thursday a.m.    My headache is now gone as of Sunday 7/25  @ 12:12 a.m.
I had general side effects within 24 hours of receiving injection (injected on Dec 30): increasing arm pain too hurt to move, body aches, 100 degree fever 12 hours later that lasted about 5 hours, tired & weak. I woke up with adverse effects on Jan 8: itchy raised rash next to injection site; ongoing today, Jan 9: rash has flattened, but remains warm, pink & itchy - appears like cellulitus. Also arm has remained slightly sore since Dec 30.
Left upper arm from shoulder to 1/2 way down upper arm, red, swollen and "bump" noted at injection site by mother. Area not painful. No fever.
Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 'vaccine administration date; Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 'vaccine administration date; This spontaneous case was reported by an emergency medical technician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 'vaccine administration date) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 'vaccine administration date) in a 27-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Mar-2022 at 3:39 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 18-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 'vaccine administration date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 'vaccine administration date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 'vaccine administration date) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 'vaccine administration date) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported.  Patient received booster dose.   Treatment medications were not reported.   This case was linked to MOD-2022-542869 (Patient Link).
pt recv vax & several months p/vax pt devel a large bruise on arm, pt was seen in Er & was found to have thrombocytopenia;sx subsided;
Red itchy rash on chest turning ino welts. Itching over entire body within 24 hours of vaccine.
Patient did not inform RN that he had already received 3 Pfizer and 1 Janssen vaccinations prior to receiving this injection.
After 2 vaccinations with varicella virus vaccine live, the patient's recent titer was negative. Unspecified medical attention was sought. In follow up, the RN reported that the patient agreed to have another titer before revaccination. In follow up, the RN reported the patient has not had another titer drawn. Additional information has been requested.
received booster dose from an expired vial of the Moderna COVID19 vaccine; This spontaneous case was reported by a consumer and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (received booster dose from an expired vial of the Moderna COVID19 vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047c21a) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: Johnsons & Johnsons COVID-19 vaccine (1st dose and Lot - 1805031) on 18-Mar-2021.    On 15-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (received booster dose from an expired vial of the Moderna COVID19 vaccine). On 15-Nov-2021, EXPIRED PRODUCT ADMINISTERED (received booster dose from an expired vial of the Moderna COVID19 vaccine) had resolved.            The patient received first dose of Johnson's & Johnsons' COVID19 vaccine on 18-Mar-2021 (lot: 1805031).  Concomitant medication of the patient was not reported.  No treatment information was provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 16-Nov-2021: Follow-up information included no new information.
Patient hospitalized S/P cesarean section. She had an uncomplicated hospital course and a healthy 8# 5 oz baby boy.
Initial report was received on 26 January 2012 from an electronic lay press article. A male patient (age and date of birth not specified) had received an injection of MENINGOCOCCAL VACCINE (manufacturer, lot number, route, site and date of administration not reported) and an unspecified amount of time later slumped over, his arms started shaking and his eyes got real big. The patient quickly recovered. The patient's medical history and concomitant medications were not reported. No further information was available at the time of the report. The patient's outcome was recovered. Documents held by sender: none.
Information received regarding pt who received vax on 09/04/1998. ON 11/07/1998, the pt experienced tingling and numbness in the right arm. On 11/14, the numbness went to the right hand. The physician noted that the pt 'did notice some numbness and lack of feeling in the left leg in late October.' The pt quit her job in November due to 'numbness in left hand and arms.' The physician noted that the pt also noted some numbness in her chest. The pt's symptoms persisted. the reporting physician noted 'suspect possible multiple sclerosis' and also considered the pt's experiences disabling. It was noted that medical intervention was required. Additional information has been requested.
Experienced some sort of paralysis after receiving vaccine; This is a spontaneous report received from a non-contactable reporter (Consumer).  A 64 year-old male patient received bnt162b2 (COMIRNATY) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PARALYSIS (medically significant), outcome "unknown", described as "Experienced some sort of paralysis after receiving vaccine".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
hard bump at the injection site; redness at injection site; rash at injection site, 2"x1.5" in size, hard bump; This case was reported by a consumer via sales rep and described the occurrence of injection site erythema in a 52-year-old female patient who received Flu Seasonal QIV Dresden (Fluarix Quadrivalent 2021-2022 season) (batch number 59N97, expiry date unknown) for prophylaxis.   Co-suspect products included flu seasonal qiv dresden pre-filled syringe device (Fluarix Tetra Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 16th October 2021, the patient received Fluarix Quadrivalent 2021-2022 season .5 ml and Fluarix Tetra Pre-Filled Syringe Device. On 26th October 2021, 10 days after receiving Fluarix Quadrivalent 2021-2022 season and Fluarix Tetra Pre-Filled Syringe Device, the patient experienced injection site erythema, injection site rash and injection site lump. On an unknown date, the outcome of the injection site erythema and injection site rash were recovered/resolved and the outcome of the injection site lump was unknown.   It was unknown if the reporter considered the injection site erythema, injection site rash and injection site lump to be related to Fluarix Quadrivalent 2021-2022 season and Fluarix Tetra Pre-Filled Syringe Device. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The patient reported redness and rash at injection site that developed 10 days after vaccination. Rash described as 2x1.5 inch in size with a hard bump at the injection site.  The patient stated the rash was similar to rash that developed following receipt of Moderna COIVD-19 vaccine, but not as itchy. When checked with pharmacy, pharmacist confirmed the patient received Fluarix and provided the lot number. The rash and redness had nearly resolved after 3 days.  The patient stated she did not seek additional care, nor was any OTC (over the counter) or nonmedical treatment used. The reporter did not consent to follow up.
Pt phoned to notify nurse that (R) arm reddened, tender, firm to touch starting 9/12 and continuing thru 9/16. Reddened area on back of (R) arm to elbow area.
Neither agreed to take the 2nd vaccine; diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea) and PRODUCT DOSE OMISSION ISSUE (Neither agreed to take the 2nd vaccine) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced DIARRHOEA (diarrhea). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Neither agreed to take the 2nd vaccine). At the time of the report, DIARRHOEA (diarrhea) and PRODUCT DOSE OMISSION ISSUE (Neither agreed to take the 2nd vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were provided.  Reportedly, the patient took medications the doctor gave her but it didn't work (doesn't know the name). It was reported that the diarrhea lasted for a month. The patient was not agree to take second dose of the vaccine.   This case was linked to MOD-2021-042913.   Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: Additional information received included outcome of the Event.
INSOMNIA/LOSE SOME SLEEP; HIGH BODY TEMPERATURE; INJECTION SITE PAIN; This spontaneous report received from a patient concerned a 39 year old male. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient had no known drug allergies, no known medical conditions and does not take any medications at the time of reporting.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A expiry: UNKNOWN) dose was not reported, administered on 02-AUG-2021 for prophylactic vaccination. No concomitant medications were reported. On 02-AUG-2021, the subject experienced insomnia/lose some sleep. On 02-AUG-2021, the subject experienced high body temperature. On 02-AUG-2021, the subject experienced injection site pain. Laboratory data included: Body temperature (NR: not provided) high. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from high body temperature, and insomnia/lose some sleep, and the outcome of injection site pain was not reported. This report was non-serious.